论文信息 - Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC). - 字舞流文

Final analysis of a phase II study of Yale-modified FOLFIRINOX (mFOLFIRINOX) in metastatic pancreatic cancer (MPC).

R. Salem | J. Lacy | J. Kortmansky | H. Hochster | Kristin Kaley | Charles Cha | C. Hahn | X. Cong | S. Stein | X. Yao | Jia Li | E. James | N. Fischbach | Xiaopan Yao